Phase II Study of Erlotinib Plus Temozolomide During and After Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme or GliosarcomaMichael D. Prados, Daphne A. Haas‐Kogan, Nicholas Butowski et al.|Journal of Clinical Oncology|2008Cited by 377